Navigation Links
Does 'Club Drug' Ecstasy Have Therapeutic Value?

By Alan Mozes
HealthDay Reporter

TUESDAY, Dec. 21 (HealthDay News) -- The recreational drug known as ecstasy may have a medicinal role to play in helping people who have trouble connecting to others socially, new research suggests.

In a study involving a small group of healthy people, investigators found that the drug -- also known as MDMA -- prompted heightened feelings of friendliness, playfulness and love, and induced a lowering of the guard that might have therapeutic uses for improving social interactions.

Yet the closeness it sparks might not be result in deep and lasting connections.

The findings "suggest that MDMA enhances sociability, but does not necessarily increase empathy," noted study author Gillinder Bedi, an assistant professor of clinical psychology at Columbia University and a research scientist at the New York State Psychiatric Institute in New York City.

The study, funded by the U.S. National Institute on Drug Abuse and conducted at the Human Behavioral Pharmacology Laboratory at the University of Chicago, was published in the Dec. 15 issue of Biological Psychiatry.

In July, another study reported that MDMA might be useful in treating post-traumatic stress disorder (PTSD), based on the drug's apparent boosting of the ability to cope with grief by helping to control fears without numbing people emotionally.

MDMA is part of a family of so-called "club drugs," which are popular with some teens and young at all night dances or "raves." These drugs, which are often used in combination with alcohol, have potentially life-threatening effects, according to the U.S. National Institute on Drug Abuse.

The newest study explored the effects of MDMA on 21 healthy volunteers, nine women and 12 men aged 18 to 38. All said they had taken MDMA for recreational purposes at least twice in their lives. They were randomly assigned to take either a low or moderate dose of MDMA, methamphetamine or a sugar pill during four sessions in about a three-week period.

Each session lasted at least 4.5 hours, or until all effects of the drug had worn off. During that time, participants stayed in a laboratory testing room, and social interaction was limited to contact with a research assistant who helped administer cognitive exams.

A moderate dose of MDMA was found to significantly increase feelings of loving, friendliness and playfulness, the researchers said, whereas the low dose of MDMA boosted feelings of loneliness.

The moderate dose also prompted a drop in the ability to accurately recognize fear in other people's faces, determined by having the participants look at a range of photos, the study found, but it did not affect the ability to perceive the shifting cues in a person's eyes or voice, determined by having the participants listen to a series of audio clips.

This effect, the Bedi and his team suggested, could help people improve their social skills by shielding them from the negative emotions of others.

In a twist, the researchers also found that methamphetamine similarly prompted feelings of friendliness and loving. In fact, those who took the drug actually rated themselves as more sociable than those taking MDMA.

As a warning, the researchers noted that MDMA might indeed facilitate socializing, but it also might impair a person's perceptive abilities and thus prompt risk-taking.

Nonetheless, the researchers suggested that MDMA might help people with PTSD as well those with autism, schizophrenia or antisocial personality disorder cope with a variety of emotional difficulties.

"More controlled research is needed to establish whether MDMA can safely and effectively add to psychotherapy for some conditions and, if so, what the mechanisms of these effects are," Bedi said.

Dr. Michael Mithoefer, author of the earlier study on MDMA and PTSD, also urged further exploration of the medicinal potential of the drug.

"First, I think it's very important that we investigate potential new therapies, and that we shouldn't be dissuaded from doing that just because something can be misused," he said. "Many things can be life-threatening or dangerous if used incorrectly. But if used in the right setting wisely, many things can also be helpful. So there's no question we should be looking into how this might benefit people who are suffering."

The results of his earlier study, which had focused on the moderate dose of MDMA, "were very promising," Mithoefer said. "Now, there's a long way to go between that and proving effectiveness. But it certainly suggests, just as these findings suggest, that the question merits further investigation."

More information

The U.S. National Institute on Drug Abuse has more on MDMA.

SOURCES: Gillinder Bedi, Ph.D., assistant professor, clinical psychology, College of Physicians and Surgeons, Columbia University, and research scientist, division on substance abuse, New York State Psychiatric Institute, New York City; Michael Mithoefer, M.D., psychiatrist, Charleston, S.C.; Dec. 15, 2010, Biological Psychiatry

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Sam's Club Hosts Health Screenings July 10
2. Sam's Club Tests Online Small Business Loan Program for Main Street
3. Youth clubs strengthen kids self image to keep them out of trouble
4. Aisle7 Experiences Strong Adoption of Wellness Marketing Products in Grocery, Club & Specialty Retail
5. Club Drug Special K Could Leave Users Incontinent
6. Chairman Al Brandel of Lions Clubs International Foundation to Appear in Washington DC's National Memorial Day Parade
7. New Australian Pregnancy and Baby Club Exceeds all Expectations in First Year
8. Memorial Day Grilling: "How-to" Secrets and Tips from Barbecue Champ Troy Black and Sam's Club For The Perfect Memorial Day Cookout
9. National Memorial Day Parade with a Pride of Lions Clubs
10. Long Beach Fit Body Boot Camp Commits 100% to Help the ‘Boys and Girls Club of Long Beach'
11. Estes Audiology and SERTOMA Club Windcrest Celebrate Better Hearing and Speech Month with Hearing Aid Roundup
Post Your Comments:
Related Image:
Does 'Club Drug' Ecstasy Have Therapeutic Value?
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
Breaking Medicine Technology: